• Fulltext

       

        Click here to view fulltext PDF


      Permanent link:
      https://www.ias.ac.in/article/fulltext/jgen/099/0047

    • Keywords

       

      IQSEC2 gene; psychiatric disorders; intellectual disability; postsynaptic density; small GTPases.

    • Abstract

       

      IQSEC2 is an X-linked gene highly expressed at the excitatory synapses where it plays a crucial role in a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor trafficking and synaptic plasticity. To date, several males and females with severe to profound intellectual disability have been reported harbouring frameshift and nonsense variants in this gene, whereas a milder phenotype has been recognized in females carrying missense pathogenic variants. Here, we report two novel IQSEC2 variants in four females with psychiatric features and otherwise variable cognitive impairment. A female (case 1) with severe verbal language learning disorder and a psychotic episode (precipitated by exposure to anti-contraceptive pill) harboured a de novo pathogenic frameshift variant (c.1170dupG,p.Gln391Alafs*5), whereas the female proband of family 2, displaying severe psychomotor regression and complex psychiatric features carried a missense variant of uncertain significance (c.770G[A,p.Ser257Asn) that was maternally inherited. Skewed X-inactivation was noted in the carrier mother. The maternal aunt, affected by schizophrenia, was found to bear the same IQSEC2 variant. We discuss the variable clinical presentation of IQSEC2 spectrum disorders and the challenging genotype–phenotype correlation, including the possible role of environmental factors as triggers for decompensation. Our report highlights how psychiatric features may be the main clinical presentation in subtle IQSEC2 phenotype, suggesting that the prevalence of IQSEC2 mutations in patients with psychiatric disorders may be underestimated.

    • Author Affiliations

       

      ANDREA ACCOGLI1 2 G. ERIC JARVIS3 ALESSANDRA SCHIAVETTO4 LAURENCE LAI4 EVANGELIA L. AMIRALI5 DANIEL ALEXANDER JIMENEZ CRUZ JIMENEZ CRUZ6 JEAN-BAPTISTE RIVIE`RE6 7 YANNIS TRAKADIS1 7

      1. Department of Medical Genetics, McGill University Health Centre, Montreal, QC, Canada
      2. DINOGMI - Università di Genova, 16126 Genoa, Italy
      3. First Episode Psychosis Program, Jewish General Hospital and McGill University, Montreal, QC H3T 1E2, Canada
      4. Neuropsychology Service, Department of Psychology and Psychiatry, CIUSS Centre West-Jewish General Hospital and McGill University, Montreal, QC H3T 1E2, Canada
      5. Département de Psychiatrie CHU Ste-Justine, Université de Montréal, Montreal, QC H3T 1C5, Canada
      6. Bioinformatics Platform, Research Institute of the McGill University Health Centre, Montréal, QC H4A 3J1, Canada
      7. Faculty of Medicine, Department of Human Genetics, McGill University, Montreal, QC H3A 1B1, Canada
    • Dates

       
    • Supplementary Material

       
  • Journal of Genetics | News

    • Editorial Note on Continuous Article Publication

      Posted on July 25, 2019

      Click here for Editorial Note on CAP Mode

© 2021-2022 Indian Academy of Sciences, Bengaluru.